Industry Leader articles are written by executives at biopharma companies, consultancies, research firms, and companies that provide services or products to sponsors. The topics are nonpromotional and focused on industrywide business issues.
How To Overcome Bottlenecks To Expedite Drug Approvals
For most drug developers, the question remains: How can we accelerate delivering new drugs to patients, while at the same time, ensuring those drugs meet stringent regulatory requirements? Here are some tips that may help.
Virtual Marking: A Flexible Option For Pharmaceuticals
Although virtual marking has been available for nearly a decade, courts have provided little specific guidance. Still, there are some points to keep in mind for virtual marking.
Realizing The Value Of Quantum Computing In Life Sciences
In the life sciences sector, quantum computing holds great potential for transforming data-heavy processes, from accelerating drug discovery to simulating clinical trials, and is one of the key technological areas we predict will impact life sciences for the better.
How To Prepare For The Next Healthcare Crisis That We Don’t See Coming
Given everything that we have learned from the COVID-19 situation, healthcare leaders can implement the following key takeaways to help them successfully weather the next storm that comes our way.
Do Biobanks Need New Strategies?
Precision medicine necessitates precision research, which necessitates getting highly specific biospecimens to researchers on demand, in alignment with their demand. Researchers shouldn’t have to adjust their research to whatever specimens are available; supply needs to fit the research.
Building A Legacy With Complex Assets
For life science executives, deciding how to manage your overall portfolio, including illiquid or complex assets, is an important step in preserving both your financial and philanthropic legacies.
How We Landed In The International Space Station
Looking back, it’s ironic that we named our company LaunchPad Medical. Our inspiration for the name came from our plan to take challenging ideas and materials and “launch” them into the medical space to revolutionize healthcare. But it never dawned on me to take our research to the International Space Station (ISS).
Taking A Strengths-Based Approach To Diversity & Inclusion
Organizations and their leaders often focus on what needs to improve, but research shows there is more to be gained from a strengths-based approach. Coaching around strengths yields greater optimism and success.
6 Tips For Contracting Or Seeking Funding From The Federal Government
With the right preparation and investments, entering the federal government market can lead to considerable growth and visibility for your company. Consider the following tips for increased chances of success.
The Great Regulatory Catch-Up: Shortcuts To Compliance For Medical Devices Manufacturers
The medical device market is about to succumb to a raft of substantial international regulatory changes, starting with Europe’s MDR in May 2020, as public pressure and industry authorities call for greater accountability for patient safety.
BEYOND THE PRINTED PAGE
A Glimpse Into David Lucchino, Cofounder And CEO Of Frequency Therapeutics
David Lucchino, cofounder and CEO of Frequency Therapeutics, discusses how he came to meet company cofounders Robert Langer, Sc.D., and Chris Loose, Ph.D., along with transitioning from med tech to biopharma.
Looking Forward Is The Job Of Every Executive
Tim Wright, CEO of MiMedx, discusses the importance of leaders looking down the road in order to keep a business sustainable.
Who Chooses the Choosers? — Ethical Considerations For Distribution Of COVID-19 Vaccines
Life Science Leader editorial advisory board member Kenneth Moch, co-founder or CEO of six life science companies, discusses ethical considerations regarding the distribution and delivery of an approved COVID-19 vaccine within a given country.
LIFE SCIENCE LEADER BLOGS
What Does Travel Look Like For You In 2021?
With the annual J.P. Morgan Healthcare conference going virtual in January of 2021, Rob Wright asks readers about their business travel plans for next year, and includes anonymized thoughts on posed questions from two Life Science Leader editorial advisory board members.
It’s Time We Ready Americans For The COVID-19 Long Haul
Rob Wright issues a call to action to everyone connected to the biopharmaceutical industry, recommending they begin communicating the realities of developing and distributing a COVID-19 vaccine by the end of this year.